Entities / Company
Daiichi.
supermarket in Obihiro, Hokkaido, Japan
- Reports this week
- 0
- Active events
- 0
- Connections
- 6
What's happening
Gone quiet
No new reports in 90+ days-
Merck and Daiichi began a Phase III study after Merck acquired co-development rights from Daiichi.Some support2 reports1 development inside
-
Merck and Daiichi successfully advanced an ADC through co-development, gaining Breakthrough Therapy designation from the FDA and orphan drug status in Europe.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Daiichi this week
News at the entities that move Daiichi most-
AstraZeneca OperationalAstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Moves Daiichi
-
Merck OperationalEli Lilly, Novo Nordisk, and Merck are currently competing in the highly competitive GLP-1 obesity market.Moves Daiichi
Connections
The 2 strongest of 6, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Operational
AstraZeneca and Daiichi are engaged in a formal partnership for joint drug development and marketing.
-
Merck Operational
Merck and Daiichi are engaged in a formal co-development partnership for a Phase III clinical study following the acquisition of co-development rights.